PAC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Buy PAC now. The chart trend is bullish (stacked moving averages) and momentum remains positive, while fundamentals (2025/Q3 growth) and the latest major analyst action (JPMorgan upgrade to Overweight) support further upside. The main near-term risk is notable hedge-fund selling, but with no negative news flow and price still below key resistance levels, the current setup is attractive for an impatient buyer seeking immediate exposure.
Trend: Bullish. The moving averages are aligned positively (SMA_5 > SMA_20 > SMA_200), indicating an established uptrend. Momentum: MACD histogram is above zero (0.321) but positively contracting, suggesting the uptrend is still intact though momentum is cooling rather than accelerating. RSI(6) at 56.47 is neutral-to-slightly-bullish (not overbought). Levels: With pre-market at 278.52, price is above the pivot (272.29), implying buyers still control the tape. Upside resistance zones are R1 284.74 then R2 292.44; near-term support is 272.29 (pivot) then S1 259.84. Given current positioning, the technical path of least resistance remains upward toward 284.7–292.4 unless price loses the pivot area.
growth: revenue +18.27% YoY, net income +39.20% YoY, EPS +40.00% YoY. No negative news in the past week (no fresh headline overhang). Statistically inferred pattern bias is modestly positive (60% chance of small gains across 1D/1W/1M windows).
Hedge funds are selling aggressively (reported selling amount up sharply over the last quarter), which can cap near-term upside and signals institutional risk-off positioning. MACD momentum is still positive but contracting, implying upside may be choppier near resistance. Prior concerns cited by analysts include subdued traffic trends and capital allocation worries (noted as reasons for past underperformance).
Latest quarter: 2025/Q3. Revenue rose to 514,577,008.43 (+18.27% YoY), net income increased to 138,830,238.95 (+39.20% YoY), and EPS grew to 0.28 (+40.00% YoY). Overall, growth is accelerating at the bottom line faster than revenue, which is supportive for the equity narrative.
Recent trend: improving. On 2025-11-13, JPMorgan upgraded the stock to Overweight from Neutral while slightly trimming the price target (MXN 465 to MXN 460). Wall Street pro view (pros): valuation/return setup improved after lagging peers; high-quality, diversified airport portfolio; potential to unlock commercial value; disciplined capital allocation. Cons: underlying traffic trends had been subdued and capital allocation has been a market concern, which could re-emerge if operating metrics soften.
